Design-based research on the way to mainstream research? Comments on the plea for phronesis by Bardone and Bauters
EDeR Educational Design Research · 2017
DOI: 10.15460/eder.1.1.1050 ↗Kurz gefasst
Fachartikel in der Zeitschrift EDeR Educational Design Research, 2017. Verfasst von Gabi Reinmann. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bardone and Bauters suggest a re-conceptualization of design-based research using the classical term "phronesis" and question some methodological developments referring to the role of intervention and theory in design-based research. This discussion article is a comment on the text of Bardone and Bauters and pursues two aims: On the one hand the term “phronesis” is connected to the traditional concept of “pädagogischer Takt” (literally: “pedagogical tact”) to stimulate a joint discourse of both traditions. On the other hand, two main suggestions of Bardone und Bauters are critically examined, namely their proposal to conceptualize intervention in design-based research exclusively as an action, and their call for deriving generalizations via experiences instead of theories. The discussion article finally argues for maintaining the integrative power of design-based research by avoiding one-sided interpretations.
Zitieren
APA
Reinmann, G. (2017). Design-based research on the way to mainstream research? Comments on the plea for phronesis by Bardone and Bauters. EDeR Educational Design Research. https://doi.org/10.15460/eder.1.1.1050
Vancouver
Reinmann G. Design-based research on the way to mainstream research? Comments on the plea for phronesis by Bardone and Bauters. EDeR Educational Design Research. 2017. doi:10.15460/eder.1.1.1050
BibTeX
@article{Reinmann2017,
author = {Reinmann, Gabi},
title = {Design-based research on the way to mainstream research? Comments on the plea for phronesis by Bardone and Bauters},
journal = {EDeR Educational Design Research},
year = {2017},
doi = {10.15460/eder.1.1.1050}
}
EUVIMED